The global membrane oxygenators market size was estimated at USD 1.45 billion in 2025 and is predicted to increase from USD 1.55 billion in 2026 to approximately USD 2.83 billion by 2035, expanding at a CAGR of 6.9% from 2026 to 2035. The market is expanding due to rising demand for advanced life-support systems in critical care, cardiac surgeries, and ECMO procedures. Continuous innovation in biocompatible materials and growing adoption across specialized healthcare facilities are driving market growth.
A membrane oxygenator is a medical device that works like an artificial lung by adding oxygen to the blood and removing carbon dioxide during procedures such as cardiac surgery and ECMO support. The membrane oxygenation market is driven by the rising incidence of cardiovascular and respiratory disorders, the increasing number of cardiac surgeries, and the growing use of ECMO in intensive care settings. Technological advancements in biocompatible care settings. Technological advancements in biocompatible materials, improved gas exchange efficiency, and compact device design are further supporting the adoption of the market.
The membrane oxygenation market is expected to grow as hospitals and critical care centers increasingly adopt advanced ECMO systems, portable oxygenators, and biocompatible membranes for safer, long-duration support. Expanding use in neonatal, pediatric, and emergency care, along with technological innovation, is creating new revenue and clinical opportunities globally.
| Metric | Value |
| Total ECMO Cases Reported Globally | 269,000 |
| Total ECMO Centers Contributing Data | 269+ |
| Neonatal ECMO Cases | 53,300 |
| Pediatric ECMO Cases | 45,700 |
| Adult ECMO Cases | 1,76,000 |
These global registry figures reflect growing ECMO use in 2024, with more than 269,000 procedures reported worldwide and widespread participation from specialized centers. The distribution across age groups shows strong adoption of membrane oxygenation technology in neonatal, pediatric, and adult critical care settings.
The hollow fiber membrane oxygenators segment dominated the market with shares of 88% in 2025 and is expected to grow at the fastest CAGR of 6.90% during the forecast period due to its high exchange efficiency, compact design, and better biocompatibility, making it ideal for long-duration ECMO and cardiac surgery procedures. Its reliability, reduced blood damage, and widespread adoption in hospitals and specialized cardiac centers further strengthened its leading position in the market.
The polypropylene (PP) segment led the market with shares of 46% in 2025 due to its excellent durability, high gas permeability, and cost-effectiveness. Its strong biocompatibility and widespread use in hollow fiber membrane oxygenators for ECMO and cardiac surgeries made it the most preferred material in hospitals and critical care settings.
The cardiopulmonary bypass surgery segment led the membrane oxygenators market with shares of 52% in 2025 due to the high number of cardiac procedures requiring temporary heart and lung support. Membrane oxygenators are essential in these surgeries for maintaining blood oxygenation and circulation, making them widely used across hospitals and cardiac centers
The adult segment held a dominant position in the market with a share of 68% in 2025 due to the higher prevalence of cardiovascular and respiratory diseases in adults, leading to more cardiac surgeries and ECMO procedures. Greater ICU admission and advanced care requirements further strengthened its revenue share in the market
The hospitals segment led the market with a share of 72% in 2025 due to the high volume of cardiac surgeries, ECMO procedures, and critical care treatment performed in hospital settings. Advanced infrastructure, skilled medical teams, and increasing patient admissions for heart and respiratory conditions strengthened its leading position.
North America dominated the market with 34% share in 2025 due to advanced healthcare infrastructure, high prevalence of cardiovascular and respiratory diseases, and widespread use on cardiovascular and respiratory diseases, and widespread use of ECMO and cardiopulmonary bypass procedures. Strong hospital networks, skilled professionals, and favorable healthcare spending further adoption and maintained the region’s leading market position in 2025.
Asia Pacific is expected to grow at the fastest CAGR due to expanding healthcare infrastructure, rising cardiac and respiratory disease cases, and increasing adoption of ECMO and advanced oxygenation technologies. Growing awareness, improved hospital access, and government investments in critical care facilities are further driving market growth across the region.
Leading companies in the membrane oxygenators market, such as Medtronic, Terumo Corporation, Getinge, and LivaNova, dominate with a wide range of oxygenation and ECMO solutions. Fresenius SE, Nipro, and MicroPort Scientific are strengthening their presence, while emerging players like Kewei Medical and smaller regional manufacturers are gaining traction in specialized and pediatric oxygenation applications.
By Product Type
By Material
By Application
By Age Group
By End User
By Region
